Skip to content

Evermine50™

by Meril Life Sciences Pvt. Ltd. India EUDAMED

Ref EVF20029

EMDN P070402010301

Regulatory status

as of 24 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDD NumberB-18904224906713 Basic UDI-DIDate24 Nov 2022RegisteredStatusActive

Coverage

1 jurisdiction

SwedenFinlandFinlandSwedenFinlandFinlandSwedenSwedenLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandFranceFranceAustriaHungaryRomaniaFranceFranceSloveniaBulgariaPortugalSpainSpainItalySpainSpainCroatiaGreeceMaltaCyprus
  • Expiring (legacy directive)
  • Not covered

European Union — CE/MDD Expiring (legacy directive)

Certificates: none listed in EUDAMED

Specification

EUDAMED · synced 24 Oct 2026

Device Name
Evermine50™ - Everolimus Eluting Coronary Stent System
Model / Reference
EVF20029
Primary DI / UDI-DI
18904224906713
Basic UDI-DI
B-18904224906713
EMDN Code
P070402010301 Coronary drug eluting stents (des) with polymers
Device Class
Class III
Market of Registration
Germany

Manufacturer details

EUDAMED SRN
IN-MF-000008308
Authorised representative
Obelis s.a. BE-AR-000000106

Other devices from Meril Life Sciences Pvt. Ltd.

See all devices from Meril Life Sciences Pvt. Ltd. →

Properties & raw data

Show properties, registry sources and raw records
  • Sterile
  • Implantable
  • Administering Medicine
  • Incorporates Medicinal Product
Other properties (7)
  • Reusable: No
  • Contains Latex: No
  • Reprocessed: No
  • Human-derived: No
  • Human Tissues: No
  • Animal Tissues: No
  • Measuring Function: No

Sources (1)

  • EUDAMED d2665c98-c61d-4a12-80c4-89452f1210ba 61 fields · synced 24 Oct 2026